Review

Published on 02 Feb 2022

Single-Cell Technologies to Decipher the Immune Microenvironment in Myeloid Neoplasms: Perspectives and Opportunities

in Cancer Immunity and Immunotherapy

Chiara Caprioli
Iman Nazari
Sara Milovanovic
Pier Giuseppe Pelicci

Frontiers in Oncology

doi 10.3389/fonc.2021.796477

5,432 views
2 citations

Original Research

Published on 02 Feb 2022

Immune Infiltration Associated MAN2B1 Is a Novel Prognostic Biomarker for Glioma

in Cancer Immunity and Immunotherapy

Xuelei Lin
Hongwei Liu
Hongyu Zhao
Shunjin Xia
Yueshuo Li
Chaoqian Wang
Qi Huang
Siyi Wanggou
Xuejun Li

Frontiers in Oncology

doi 10.3389/fonc.2022.842973

3,606 views
5 citations

Original Research

Published on 27 Jan 2022

Thymic Polypeptide Fraction Biomodulina T Decreases Exhausted and Terminally Differentiated EMRA T Cells in Advanced Lung Cancer Patients Treated With Platinum-Based Chemotherapy

in Cancer Immunity and Immunotherapy

Gisela María Suárez
Mauricio Catalá
Yadira Peña
Susana Portela
Ana Laura Añé-Kourí
Amnely González
Patricia Lorenzo-Luaces
Manuel Díaz
María de los A. Molina
Karla Pereira

Frontiers in Oncology

doi 10.3389/fonc.2022.823287

2,512 views
5 citations

Original Research

Published on 26 Jan 2022

PET/CT Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients

in Cancer Immunity and Immunotherapy

Xiaoxiang Rong
Jinyu Lv
Yantan Liu
Zhaojun Wang
Dongqiang Zeng
Yuedan Li
Shaowei Li
Jianhua Wu
Zheyu Shen
Min Shi

Frontiers in Oncology

doi 10.3389/fonc.2021.802257

5,666 views
19 citations

Review

Published on 25 Jan 2022

TCR-T Immunotherapy: The Challenges and Solutions

in Cancer Immunity and Immunotherapy

Yating Liu
Xin Yan
Fan Zhang
Xiaoxia Zhang
Futian Tang
Zhijian Han
Yumin Li

Frontiers in Oncology

doi 10.3389/fonc.2021.794183

40,651 views
59 citations

Review

Published on 25 Jan 2022

(Im)maturity in Tumor Ecosystem

in Cancer Immunity and Immunotherapy

Keywan Mortezaee
Jamal Majidpoor

Frontiers in Oncology

doi 10.3389/fonc.2021.813897

3,573 views
34 citations

Original Research

Published on 24 Jan 2022

An Integrated Pan-Cancer Analysis of 33 Human Cancers Reveals the Potential Clinical Implications and Immunotherapeutic Value of C-X-C Motif Chemokine Ligand 13

in Cancer Immunity and Immunotherapy

Huanyu Zhang
Honghao Yin
Jing Chen
Yuan Yuan

Frontiers in Oncology

doi 10.3389/fonc.2022.791962

3,305 views
3 citations

Original Research

Published on 21 Jan 2022

Neutralizing Anti-IL-17A Antibody Demonstrates Preclinical Activity Enhanced by Vinblastine in Langerhans Cell Histiocytosis

in Cancer Immunity and Immunotherapy

Selma Olsson Åkefeldt
Mohamad Bachar Ismail
Alexandre Belot
Giulia Salvatore
Nathalie Bissay
Désirée Gavhed
Maurizio Aricò
Jan-Inge Henter
Hélène Valentin
Christine Delprat

Frontiers in Oncology

doi 10.3389/fonc.2021.780191

2,486 views
1 citation

Original Research

Published on 18 Jan 2022

Development of a Novel Anti-CD19 CAR Containing a Fully Human scFv and Three Costimulatory Domains

in Cancer Immunity and Immunotherapy

Yupanun Wutti-in
Jatuporn Sujjitjoon
Nunghathai Sawasdee
Aussara Panya
Katesara Kongkla
Pornpimon Yuti
Petlada Yongpitakwattana
Chutamas Thepmalee
Mutita Junking
Thaweesak Chieochansin

Frontiers in Oncology

doi 10.3389/fonc.2021.802876

16,192 views
16 citations

Review

Published on 14 Jan 2022

The Emerging Role of Tissue-Resident Memory CD8+ T Lymphocytes in Human Digestive Tract Cancers

in Cancer Immunity and Immunotherapy

Xinyu Mei
Huan Li
Xinpeng Zhou
Min Cheng
Kele Cui

Frontiers in Oncology

doi 10.3389/fonc.2021.819505

5,443 views
9 citations

Case Report

Published on 13 Jan 2022

Case Report: Favorable Response and Manageable Toxicity to the Combination of Camrelizumab, Oxaliplatin, and Oral S-1 in a Patient With Advanced Epstein–Barr Virus-Associated Gastric Cancer

in Cancer Immunity and Immunotherapy

Wanrui Lv
Ke Cheng
Xiaofen Li
Lusi Feng
Hancong Li
Jia Li
Chen Chang
Dan Cao

Frontiers in Oncology

doi 10.3389/fonc.2021.759652

2,669 views
5 citations

Original Research

Published on 12 Jan 2022

Pan-Cancer Analysis Shows Enrichment of Macrophages, Overexpression of Checkpoint Molecules, Inhibitory Cytokines, and Immune Exhaustion Signatures in EMT-High Tumors

in Cancer Immunity and Immunotherapy

Jayesh Kumar Tiwari
Shloka Negi
Manju Kashyap
Sheikh Nizamuddin
Amar Singh
Arun Khattri

Frontiers in Oncology

doi 10.3389/fonc.2021.793881

6,712 views
12 citations

Review

Published on 12 Jan 2022

Interactions Between Anti-Angiogenic Therapy and Immunotherapy in Glioblastoma

in Cancer Immunity and Immunotherapy

Saket Jain
Eric J. Chalif
Manish K. Aghi

Frontiers in Oncology

doi 10.3389/fonc.2021.812916

5,909 views
22 citations

Case Report

Published on 10 Jan 2022

Case Report: First Case of Consolidation Immunotherapy After Definitive Chemoradiotherapy in Mediastinal Lymph Node Metastatic Sarcomatoid Carcinoma

in Cancer Immunity and Immunotherapy

Yu Wang
Lin Yang
Jianyang Wang
Lin Gui
Wei Li
Zhiqiang Liu
Xiangyu Ma
Yin Yang
Luhua Wang
Nan Bi

Frontiers in Oncology

doi 10.3389/fonc.2021.788856

2,090 views
3 citations

Perspective

Published on 10 Jan 2022

Bioinspired Membrane-Coated Nanoplatform for Targeted Tumor Immunotherapy

in Cancer Immunity and Immunotherapy

Dan Mu
Pan He
Yesi Shi
Lai Jiang
Gang Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.819817

3,099 views
4 citations

Review

Published on 07 Jan 2022

Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy

in Cancer Immunity and Immunotherapy

Evelien A. J. van Genugten
Jetty A. M. Weijers
Sandra Heskamp
Manfred Kneilling
Michel M. van den Heuvel
Berber Piet
Johan Bussink
Lizza E. L. Hendriks
Erik H. J. G. Aarntzen

Frontiers in Oncology

doi 10.3389/fonc.2021.786089

5,465 views
4 citations

Navigation group

Articles

Single-Cell Technologies to Decipher the Immune Microenvironment in Myeloid Neoplasms: Perspectives and Opportunities

Immune Infiltration Associated MAN2B1 Is a Novel Prognostic Biomarker for Glioma

Thymic Polypeptide Fraction Biomodulina T Decreases Exhausted and Terminally Differentiated EMRA T Cells in Advanced Lung Cancer Patients Treated With Platinum-Based Chemotherapy

PET/CT Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients

TCR-T Immunotherapy: The Challenges and Solutions

(Im)maturity in Tumor Ecosystem

An Integrated Pan-Cancer Analysis of 33 Human Cancers Reveals the Potential Clinical Implications and Immunotherapeutic Value of C-X-C Motif Chemokine Ligand 13

Neutralizing Anti-IL-17A Antibody Demonstrates Preclinical Activity Enhanced by Vinblastine in Langerhans Cell Histiocytosis

Development of a Novel Anti-CD19 CAR Containing a Fully Human scFv and Three Costimulatory Domains

The Emerging Role of Tissue-Resident Memory CD8+ T Lymphocytes in Human Digestive Tract Cancers

Case Report: Favorable Response and Manageable Toxicity to the Combination of Camrelizumab, Oxaliplatin, and Oral S-1 in a Patient With Advanced Epstein–Barr Virus-Associated Gastric Cancer

Pan-Cancer Analysis Shows Enrichment of Macrophages, Overexpression of Checkpoint Molecules, Inhibitory Cytokines, and Immune Exhaustion Signatures in EMT-High Tumors

Interactions Between Anti-Angiogenic Therapy and Immunotherapy in Glioblastoma

Case Report: First Case of Consolidation Immunotherapy After Definitive Chemoradiotherapy in Mediastinal Lymph Node Metastatic Sarcomatoid Carcinoma

Bioinspired Membrane-Coated Nanoplatform for Targeted Tumor Immunotherapy

Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy